These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 77190)

  • 1. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
    Kemeny N; Yagoda A; Burchenal JH
    Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
    Burchenal JH; O'Toole T; Kalaher K; Chisholm J
    Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tissue distribution and fate of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and 1-beta-D-arabinofuranosyl-5-fluorocytosine in rats.
    Chou TC; Vidal P; Phillips FS
    Cancer Treat Rep; 1977 Jul; 61(4):617-24. PubMed ID: 69496
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ; Shani A; Rubin J; Moertel CG
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
    Brugarolas A; Buesa JM; Lacave AJ; Gracia Marco M; Valle Pereda M
    Cancer Clin Trials; 1978; 1(4):289-95. PubMed ID: 93030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of Baker's antifol in advanced colorectal cancer.
    Padilla F; Correa J; Buroker T; Vaitkevicius VK
    Cancer Treat Rep; 1978 Apr; 62(4):553-4. PubMed ID: 350391
    [No Abstract]   [Full Text] [Related]  

  • 10. Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
    Falkson G; Falkson HC; du Plessis HE; Meyer TE
    Cancer Clin Trials; 1980; 3(4):341-4. PubMed ID: 6159121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of metronidazole therapy for advanced colorectal carcinoma.
    Frytak S; Moertel CG; Childs DS; Schutt AJ; Albers JW
    Cancer Treat Rep; 1978 Mar; 62(3):483-5. PubMed ID: 348320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of ifosfamide and mesna in advanced colorectal cancer.
    Kemeny N; Reichman B; Dougherty J; Lipperman R; Cheng E
    Cancer Treat Rep; 1987 Jun; 71(6):663-4. PubMed ID: 3107815
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of cytosine arabinoside in advanced large bowel cancer.
    Cullinan SA; O'Connell MJ; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ; Frytak S; Rubin J
    Cancer Treat Rep; 1977 Dec; 61(9):1725-6. PubMed ID: 340037
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial.
    Eisenstaedt RS; Neilan BA; Bartolucci A
    Cancer Treat Rep; 1987; 71(7-8):779-80. PubMed ID: 3300971
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of bisantrene in advanced colorectal carcinoma.
    Ahmed T; Kemeny NE; Michaelson RA; Harper HD
    Cancer Treat Rep; 1983 Mar; 67(3):307-8. PubMed ID: 6831479
    [No Abstract]   [Full Text] [Related]  

  • 20. Carboplatin for advanced colorectal carcinoma: a phase II study.
    Perry DJ; Weiss RB; Creekmore SP; Micetich KC; Curt GA
    Cancer Treat Rep; 1986 Feb; 70(2):301-2. PubMed ID: 3512081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.